Filing Flows › Comparisons › ONMD vs ISPC
OneMedNet vs iSpecimen: ONMD and ISPC compared
OneMedNet is the larger company: $292K of revenue in its latest quarter (Q2 2026) against $152K for iSpecimen (Q2 2026). OneMedNet is growing faster (+88% against -79% a year earlier). OneMedNet is more profitable, with an operating margin of -774.3% against -897.1%.
Where the money goes: ONMD and ISPC
OneMedNet (ONMD) · Q2 2026
OneMedNet, Q2 2026: revenue $292K (+88% year over year), operating margin -774.3%, net loss $2.2M, operating cash flow −$1.9M. The chart follows the revenue to costs, profit and cash.
iSpecimen (ISPC) · Q2 2026
iSpecimen, Q2 2026: revenue $152K (-79% year over year), operating margin -897.1%, net loss $1.4M, operating cash flow −$690K. The chart follows the revenue to costs, profit and cash.
| OneMedNet (ONMD) | iSpecimen (ISPC) | |
|---|---|---|
| Latest quarter | Q2 2026 | Q2 2026 |
| Revenue | $292K | $152K |
| Revenue growth, Y/Y | +88% | -79% |
| Operating margin | -774.3% | -897.1% |
| Net earnings | −$2.2M | −$1.4M |
| Net margin | -743.8% | -896.9% |
| Operating cash flow | −$1.9M | −$690K |
Where the revenue comes from
iSpecimen
- Product: $125K (83%)
- Shipping and Handling: $27K (17%)
Questions
Which is bigger, OneMedNet or iSpecimen?
OneMedNet is the larger company: $292K of revenue in its latest quarter (Q2 2026) against $152K for iSpecimen (Q2 2026).
Is OneMedNet or iSpecimen growing faster?
OneMedNet is growing faster (+88% against -79% a year earlier).
Which is more profitable, OneMedNet or iSpecimen?
OneMedNet is more profitable, with an operating margin of -774.3% against -897.1%.
More: OneMedNet earnings · how OneMedNet makes money · iSpecimen earnings · how iSpecimen makes money
From the companies' latest 10-Q, 10-K or earnings release (10-Q filed Aug 14, 2026; 10-Q filed Aug 14, 2026). Fiscal quarters can end on different dates. Not investment advice.